Stem Cell Transplant Complications Completed Phase 4 Trials for Haloperidol (DB00502)

IndicationStatusPhase
DBCOND0081111 (Stem Cell Transplant Complications)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03489551Feasibility of Prophylactic Haldol to Prevent Delirium in Cancer PatientsSupportive Care